CSIMarket
 


Scynexis inc   (SCYX)
Other Ticker:  
 

Scynexis Inc 's Leverage Ratio

SCYX's quarterly Leverage Ratio and Total Liabilities, Equity growth




SCYX Leverage Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Equity Change 410.34 % 301.61 % 76.49 % 55.59 % -39.12 %
Y / Y Total Liabilities Change 128.11 % 111.77 % 80.4 % -1.79 % 27.05 %
Leverage Ratio MRQ 2.75 2.86 3.51 2.84 6.15
Overall Ranking # # # # #
Seq. Equity Change 24.67 % 13.91 % 138.1 % 50.92 % -1.89 %
Seq. Total Liabilities Change 19.78 % -7.06 % 193.87 % -30.27 % 11.2 %



Leverage Ratio second quarter 2021 Comment
Despite net new borrowings of 19.78% Scynexis Inc managed to improve Leverage Ratio in the second quarter 2021 to 2.75, above company's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the second quarter 2021, 303 other companies have achieved lower Leverage Ratio than Scynexis Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are SCYX Customers?
Leverage Ratio second quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 304
Healthcare Sector # 736
Overall Market # 2902


Leverage Ratio Statistics
High Average Low
6.15 1.65 0.07
(Jun 30 2020)   (Sep 30 2015)




Financial Statements
Scynexis Inc 's Equity $ 32 Millions Visit SCYX's Balance sheet
Scynexis Inc 's Total Liabilities $ 89 Millions Visit SCYX's Balance sheet
Source of SCYX's Sales Visit SCYX's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingJun 30 2021, within Major Pharmaceutical Preparations Industry Leverage RatioJun 30 2021 MRQ Total LiabilitiesJun 30 2021 MRQ Equity
Dicerna Pharmaceuticals Inc   6.55 $ 727.418  Millions$ 111.074  Millions
Dynavax Technologies Corp  6.38 $ 531.632  Millions$ 83.380  Millions
Xeris Pharmaceuticals Inc   6.11 $ 121.508  Millions$ 19.888  Millions
Eli Lilly And Company  5.93 $ 39,507.300  Millions$ 6,663.500  Millions
Avid Bioservices Inc   5.06 $ 225.895  Millions$ 44.636  Millions
Sarepta Therapeutics Inc   4.50 $ 2,184.721  Millions$ 485.108  Millions
Epizyme Inc   4.21 $ 284.920  Millions$ 67.629  Millions
Tricida Inc   4.16 $ 145.211  Millions$ 34.929  Millions
Acura Pharmaceuticals Inc  3.96 $ 1.514  Millions$ 0.382  Millions
Maravai Lifesciences Holdings Inc   3.90 $ 1,297.836  Millions$ 333.141  Millions
Sesen Bio Inc   3.88 $ 191.698  Millions$ 49.349  Millions
Harrow Health Inc   3.67 $ 83.763  Millions$ 22.848  Millions
Recro Pharma Inc   3.63 $ 96.014  Millions$ 26.416  Millions
Sonnet Biotherapeutics Holdings Inc   3.45 $ 4.716  Millions$ 1.369  Millions
Teva Pharmaceutical Industries Ltd  3.44 $ 38,871.000  Millions$ 11,311.000  Millions
Immunogen inc   3.40 $ 232.981  Millions$ 68.465  Millions
Ionis Pharmaceuticals Inc   3.29 $ 1,914.395  Millions$ 582.674  Millions
Mei Pharma Inc   3.21 $ 132.736  Millions$ 41.362  Millions
Alnylam Pharmaceuticals Inc   3.11 $ 2,656.067  Millions$ 853.362  Millions
Scynexis inc   2.75 $ 88.811  Millions$ 32.320  Millions
Amicus Therapeutics inc   2.68 $ 572.982  Millions$ 213.910  Millions
Alpine Immune Sciences Inc   2.65 $ 115.987  Millions$ 43.831  Millions
Phibro Animal Health Corp  2.53 $ 602.796  Millions$ 238.529  Millions
Akebia Therapeutics Inc   2.50 $ 437.232  Millions$ 174.631  Millions
Assertio Holdings inc   2.38 $ 219.751  Millions$ 92.265  Millions
Revance Therapeutics Inc   2.36 $ 439.132  Millions$ 186.235  Millions
Chembio Diagnostics Inc   2.28 $ 34.473  Millions$ 15.103  Millions
Zoetis Inc   2.23 $ 9,719.000  Millions$ 4,352.000  Millions
China Pharma Holdings Inc   2.06 $ 13.420  Millions$ 6.525  Millions
Sonoma Pharmaceuticals Inc  2.06 $ 9.500  Millions$ 4.621  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SURG's Profile

Stock Price

SURG's Financials

Business Description

Fundamentals

Charts & Quotes

SURG's News

Suppliers

SURG's Competitors

Customers & Markets

Economic Indicators

SURG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071